Cyteir Therapeutics Inc (CYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1998 | 12-1997 | 09-1997 | 06-1997 | 03-1997 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 31,200 | 113,600 | 83,000 | 54,700 | 26,900 |
| Depreciation Amortization | 22,400 | 78,800 | 58,700 | 38,400 | 19,600 |
| Other Working Capital | -9,400 | -48,400 | -35,200 | -39,500 | -17,100 |
| Other Operating Activity | -18,500 | -12,300 | -18,000 | -16,800 | -16,400 |
| Operating Cash Flow | $25,700 | $131,700 | $88,500 | $36,800 | $13,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -24,700 | -91,400 | -58,900 | -34,700 | -14,200 |
| Net Acquisitions | 0 | -248,300 | -344,000 | 0 | 0 |
| Other Investing Activity | 0 | 2,100 | 101,700 | 101,800 | 101,800 |
| Investing Cash Flow | $-24,700 | $-337,600 | $-301,200 | $67,100 | $87,600 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 22,000 | 194,200 | 216,000 | -100,500 | -90,700 |
| Financing Cash Flow | $22,000 | $194,200 | $216,000 | $-100,500 | $-90,700 |
| Exchange Rate Effect | -100 | -2,300 | -1,500 | -1,100 | -900 |
| Beginning Cash Position | 6,400 | 20,400 | 20,400 | 20,400 | 20,400 |
| End Cash Position | 29,300 | 6,400 | 22,200 | 22,700 | 29,400 |
| Net Cash Flow | $22,900 | $-14,000 | $1,800 | $2,300 | $9,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 25,700 | 131,700 | 88,500 | 36,800 | 13,000 |
| Free Cash Flow | 25,700 | 131,700 | 88,500 | 36,800 | 13,000 |